Psychosis associated to Parkinson's disease in the early stages: Relevance of cognitive decline and depression

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 1, 2012, Pages 76-82

  Morgante, Letterio ^a   Colosimo, Carlo ^b   Antonini, Angelo ^c,d   Marconi, Roberto ^e   Meco, Giuseppe ^b   Pederzoli, Massimo ^f   Pontieri, Francesco E ^g   Cicarelli, Giulio ^h   Abbruzzese, Giovanni ⁱ   Zappulla, Salvatore ^j   Ramat, Silvia ^k   Manfredi, Michela ^l   Bottacchi, Edo ^m   Abrignani, Michele ⁿ   Berardelli, Alfredo ^o   Cozzolino, Autilia ^p   Paradiso, Claudio ^c   De Gaspari, Danilo ^c   Morgante, Francesca ^a   Barone, Paolo ^p   Caravona, N ^q   Braga, M ^q   Pellicano, C ^q   Petretta, V ^q   Di Brigida, G ^q   Meoni, S ^q   Pepe, F ^q   Di Giovanni, M ^q   Modica, C ^q   Mucchiut, M ^q   Bartalini, S ^q   Cossu, G ^q   Pennisi, F ^q   Bartolomei, L ^q   L'Erario, R ^q   Tiple, D ^q   Petrone, A ^q   Avarello, T P ^q   Bentivoglio, A R ^q   Scala, R ^q   Gaglio, R M ^q   Giglia, L ^q   Ceravolo, R ^q   Nicoletti, A ^q   Trianni, G ^q   Martinelli, P ^q   Rocco, M ^q   Moschella, V ^q   Volpe, G ^q   Perini, M ^q   Capus, L ^q   Simone, P ^q   Iemolo, F ^q   Grasso, L ^q   Savica, R ^q   Sensi, M ^q   Baratti, M ^q   Pezzoli, G ^q   Ceravolo, M G ^q   Del Dotto, P ^q   Scaglioni, A ^q   Soliveri, P ^q   Mauro, A ^q   Troianiello, B ^q   Consoli, D ^q   Cannas, A ^q   Marano, R ^q   Dumitriu, A ^q   Sgarbi, S ^q   Rapisarda, A ^q   Rizzoli, S ^q   Zanoli, L ^q   Manfredi, A ^q   more..

^a UNIVERSITY OF MESSINA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c PARKINSON INSTITUTE   (Italy)

^d IRCCS SAN CAMILLO HOSPITAL   (Italy)

^e MISERICORDIA HOSPITAL   (Italy)

^f Ospedale Civile   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h AORN San Giuseppe Moscati   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j Ospedale Umberto I   (Italy)

^k Azienda Ospedaliera Universitaria   (Italy)

^l IRCCS   (Italy)

^m Ospedale Regionale   (Italy)

ⁿ UO Neurologia   (Italy)

^o SAPIENZA UNIVERSITY OF ROME   (Italy)

^p UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^q NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; APATHY; ARTICLE; ATTENTION DISTURBANCE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HALLUCINATION; HUMAN; ILLUSION; INCIDENCE; INSOMNIA; JEALOUS DELUSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; OBSERVATIONAL STUDY; ONSET AGE; PARKINSON DISEASE; PERSECUTORY DELUSION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; SLEEP DISORDER; SYMPTOMATOLOGY;

EID: 84155172794     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-300043     Document Type: Article

References (37)

1. Aarsland D, Larsen JP, Tandberg E, et al. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000;48:938-42. (Pubitemid 30637303)
2. Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003;60:1756-61. (Pubitemid 36737069)
3. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-45. (Pubitemid 30162723)
4. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996;53:1265-8. (Pubitemid 26425072)
5. Papapetropoulos S, Argyriou AA, Ellul J. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol 2005;252:1223-8. (Pubitemid 41443623)
6. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005;4:605-10. (Pubitemid 41317294)
7. Diederich NJ, Fenelon G, Stebbins G, et al. Hallucinations in Parkinson disease. Nat Rev Neurol 2009;5:331-42.
8. Pacchetti C, Manni R, Zangaglia R, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 2005;20:1439-48. (Pubitemid 43072652)
9. Marsh L, Williams JR, Rocco M, et al. Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology 2004;63:293-300. (Pubitemid 38971129)
10. Goetz CG, Leurgans S, Pappert EJ, et al. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 2001;57:2078-82. (Pubitemid 33126877)
11. Biglan KM, Holloway RG Jr, McDermott MP, et al. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology 2007;69:187-95. (Pubitemid 47051724)
12. Holloway RG, Shoulson I, Fahn S, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol 2004;61:1044-53. (Pubitemid 38915945)
13. Antonini A, Colosimo C, Marconi R, et al. The PRIAMO study: background, methods and recruitment. Neurol Sci 2008;29:61-5. (Pubitemid 351696406)
14. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009;24:1641-9.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9. (Pubitemid 29046907)
16. American Academy of Sleep Medicine. ICSD - International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Chicago, IL: American Academy of Sleep Medicine, 2001.
17. Bursac Z, Gauss CH, Williams DK, et al. A purposeful selection of variables macro for logistic regression. SAS Global Forum Proceedings 2007;173:1-5.
18. Aarsland D, Larsen JP, Cummins JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999;56:595-601. (Pubitemid 29218155)
19. de Maindreville AD, Fenelon G, Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 2005;20:212-17. (Pubitemid 40361126)
20. Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995;28:240-58.
21. Aarsland D, Bronnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007;78:36-42. (Pubitemid 46048261)
22. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001;70:727-33. (Pubitemid 32554201)
23. Giladi N, Treves TA, Paleacu D, et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000;107:59-71. (Pubitemid 30077043)
24. Goetz CG, Wuu J, Curgian LM, et al. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 2005;64:81-6. (Pubitemid 40082941)
25. Biousse V, Skibell BC, Watts RL, et al. Ophthalmologic features of Parkinson's disease. Neurology 2004;62:177-80. (Pubitemid 38167121)
26. Diederich NJ, Goetz CG, Raman R, et al. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998;21:289-95. (Pubitemid 28491429)
27. Grossi D, Trojano L, Pellecchia MT, et al. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients. Int J Geriatr Psychiatry 2005;20:668-73. (Pubitemid 41131778)
28. Ramirez-Ruiz B, Junque C, Marti MJ, et al. Cognitive changes in Parkinson's disease patients with visual hallucinations. Dement Geriatr Cogn Disord 2007;23:281-8. (Pubitemid 46631933)
29. Santangelo G, Trojano L, Vitale C, et al. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Mov Disord 2007;22:2418-25. (Pubitemid 351155990)
30. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-8. (Pubitemid 32554202)
31. Sinforiani E, Pacchetti C, Zangaglia R, et al. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord 2008;23:1441-5.
32. Nebe A, Ebersbach G. Selective diplopia in Parkinson's disease: a special subtype of visual hallucination? Mov Disord 2007;22:1175-8. (Pubitemid 47067231)
33. Ravina B, Marder K, Fernandez HH, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord 2007;22:1061-8. (Pubitemid 47067214)
34. Goetz CG, Fan W, Leurgans S, et al. The malignant course of "benign hallucinations"in Parkinson disease. Arch Neurol 2006;63:713-16.
35. Goetz CG, Vogel C, Tanner CM, et al. Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology 1998;51:811-14. (Pubitemid 28449264)
36. Hanssen M, Bak M, Bijl R, et al. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005;44:181-91. (Pubitemid 40873432)
37. Goetz CG, Fan W, Leurgans S. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening. Mov Disord 2008;23:1541-5.